15 Aug 2011 14:05
AIM: ODX
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director/PDMR Shareholding
Omega, the AIM listed medical diagnostics company, announces that on 12 August 2011 the following Director was granted options over ordinary shares of 4p each in the Company ('Ordinary Shares'):
Number of options over Ordinary Shares
| |
Jag Grewal, Group Sales & Marketing Director | 100,000 |
The options have an exercise price of 13.25 pence per Ordinary Share. The vesting period begins one year after grant and the options will lapse on the tenth anniversary of grant if not exercised.
The options are granted under the Omega Diagnostics Group PLC EMI Option Scheme.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | |
Kieron Harbinson, Group Finance Director | www.omegadiagnostics.com |
Cenkos Securities plc | Tel: 020 7397 8900 |
Ian Soanes Elizabeth Bowman | |
Walbrook PR Limited | |
Paul McManus | Tel: 020 7933 8787 Mob: 07980 541 893 paul.mcmanus@walbrookpr.com
|
Fiona Henson | Tel: 020 7933 8795 |
Mob: 07886 335 992 | |
fiona.henson@walbrookpr.com |
ODX.L (ODX)